Drug and pharmaceutical recalls
17658 federal recalls on file. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2026-01-14FDA-DrugAvKAREClass IIStop using AvKARE Rosuvastatin 10 mg tablets
Out of specification for dissolution.
- 2026-01-14FDA-DrugMedinatura New Mexico, inc.Class IStop using ClearLife Allergy Nasal Spray
Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.
- 2026-01-14FDA-DrugMedinatura New Mexico, inc.Class IStop using MediNatura ReBoost Nasal Spray
Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.
- 2026-01-14FDA-DrugSpecGx, LLCClass IICheck your SpecGx pain medication bottle
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
- 2026-01-14FDA-DrugSpecGx, LLCClass IICheck your SpecGx oxycodone tablets
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
- 2026-01-14FDA-DrugSignature Formulations, LLCClass IIStop using ORL Kids Natural Toothpaste
cGMP Deviations
- 2026-01-14FDA-DrugSignature Formulations, LLCClass IIStop using ORL Kids Mouthwash Bubblegum
cGMP Deviations
- 2026-01-14FDA-DrugImprimis NJOF, LLCClass IIStop using Imprimis Tri-Moxi eye injections
Presence of particulate matter - Glass like particles.
- 2026-01-14FDA-DrugImprimis NJOF, LLCClass IIStop using Imprimis NJOF eye injection
Presence of particulate matter - Glass like particles.
- 2026-01-14FDA-DrugImprimis NJOF, LLCClass IIStop using Imprimis eye injection immediately
Presence of particulate matter - Glass like particles.
- 2026-01-14FDA-DrugAlembic Pharmaceuticals LimitedClass IIIStop using Alembic Fesoterodine Fumarate tablets
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
- 2026-01-07FDA-DrugZydus Pharmaceuticals (USA) IncClass IIICheck your trazodone tablets for dents
Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.
- 2026-01-07FDA-DrugGlenmark Pharmaceuticals Inc., USAClass IIStop using Glenmark Ondansetron 4mg tablets
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
- 2026-01-07FDA-DrugNovo Nordisk Inc.Class IIStop using Novo Nordisk Wegovy injection pens
Presence of Particulate Matter: Hair was found in a prefilled syringe
- 2026-01-07FDA-DrugNovo Nordisk Inc.Class IIStop using Wegovy 0.5 mg prefilled pens (specific lots)
Presence of Particulate Matter: Hair was found in a prefilled syringe
- 2026-01-07FDA-DrugCareFusion 213, LLCClass IIStop using BD ChloraPrep Triple Swabsticks
Lack of Assurance of Sterlity
- 2025-12-31FDA-DrugMerck Sharp & Dohme LLCClass IIStop using Merck Noxafil Powdermix immediately
Presence of particulate matter: potential presence of metal particulates in the product.
- 2025-12-31FDA-DrugMerck Sharp & Dohme LLCClass IIStop using Merck Emend suspension lot Z014503
Presence of particulate matter: potential presence of metal particulates in the product.
- 2025-12-24FDA-DrugSUN PHARMA /TAROClass IIStop using Taro Ciclopirox Shampoo 1%
Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint
- 2025-12-24FDA-DrugPreferred Pharmaceuticals, Inc.Class IIStop using Preferred Pharmaceuticals ondansetron ODT
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
- 2025-12-24FDA-DrugSOMERSET THERAPEUTICS LLCClass IIIStop using Somerset Therapeutics cisatracurium besylate
Subpotent product:out of specification assay results observed during long term stability testing.
- 2025-12-24FDA-DrugSOMERSET THERAPEUTICS LLCClass IIIStop using Somerset cisatracurium besylate injection
Subpotent product:out of specification assay results observed during long term stability testing.
- 2025-12-24FDA-DrugSOMERSET THERAPEUTICS LLCClass IIICheck cisatracurium besylate vials for affected lots
Subpotent product:out of specification assay results observed during long term stability testing.
- 2025-12-24FDA-DrugGolden State Medical Supply Inc.Class IIStop using Golden State Medical Supply baclofen
Presence of Foreign Tablets/Capsules
- 2025-12-24FDA-DrugNovocol Pharmaceutical of Canada, Inc.Class IIStop using OraVerse injection cartridges
Defective container: cracked/broken cartridges
- 2025-12-24FDA-DrugNovocol Pharmaceutical of Canada, Inc.Class IIStop using Novocol Carbocaine 3% injection
Defective container: cracked/broken cartridges
- 2025-12-24FDA-DrugNovocol Pharmaceutical of Canada, Inc.Class IIStop using Novocol Mepivacaine HCI injection
Defective container: cracked/broken cartridges
- 2025-12-24FDA-DrugNovocol Pharmaceutical of Canada, Inc.Class IIStop using Novocol Mepivacaine injection cartridges
Defective container: cracked/broken cartridges
- 2025-12-24FDA-DrugNovocol Pharmaceutical of Canada, Inc.Class IIStop using recalled Polocaine dental anesthetic
Defective container: cracked/broken cartridges
- 2025-12-24FDA-DrugNovocol Pharmaceutical of Canada, Inc.Class IIStop using Novocol lidocaine-epinephrine cartridges
Defective container: cracked/broken cartridges
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief